We are live on ! Find out more
NRC

North Run Capital Portfolio holdings

AUM $43.5M
1-Year Est. Return 38.24%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
–
AUM
$984M
AUM Growth
+$195M
Cap. Flow
+$125M
Cap. Flow %
12.68%
Top 10 Hldgs %
60.41%
Holding
34
New
10
Increased
4
Reduced
11
Closed
4

Top Buys

Rank Stock Value
1
TIBX
TIBCO SOFTWARE INC
TIBX
+$54.5M
2
VC icon
Visteon
VC
+$49.1M
3
INXN
Interxion Holding N.V.
INXN
+$44.6M
4
SIR
SELECT INCOME REIT
SIR
+$28.3M
5
GM icon
General Motors
GM
+$25.3M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$54.3M
2
AET
Aetna Inc
AET
+$29M
3
ACTG icon
Acacia Research
ACTG
+$22.2M
4
HNT
HEALTH NET INC
HNT
+$20.5M
5
QVCGA
QVC Group Inc Series A
QVCGA
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 31.66%
2 Consumer Discretionary 22.49%
3 Financials 11.44%
4 Industrials 8.2%
5 Real Estate 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EYPT icon
26
EyePoint Inc
EYPT
$1.03B
$8.79M 0.89%
214,409
– –
LORL
27
DELISTED
Loral Space and Communications, Inc.
LORL
$7.07M 0.72%
100,000
-43,035
-30% -$3.28M
CPS icon
28
Cooper-Standard Automotive
CPS
$523M
$6.91M 0.7%
+97,852
New +$5.8M
LQDT icon
29
PUT
Liquidity Services
LQDT
$1.22B
$5.46M 0.55%
+209,600
New +$5.1M
DLIA
30
DELISTED
DELIA*S INC
DLIA
$2.3M 0.23%
2,738,096
-384,468
-12% -$350K
ACTG icon
31
Acacia Research
ACTG
$428M
– –
-1,528,524
Closed -$22.2M
MCGC
32
DELISTED
MCG CAP CORP
MCGC
– –
-2,896,464
Closed -$12.7M
NDZ
33
DELISTED
NORDION INC COM STK (CDA)
NDZ
– –
-1,414,200
Closed -$12M
BODY
34
DELISTED
BODY CENTRAL CORP COM STK
BODY
– –
-49,542
Closed -$195K
1
2

Similar funds

ACM
Axel Capital Management New York $47.4M AUM 2.75% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
JI
Jeereddi Investments Los Angeles, California $38.1M AUM 12.15% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return
BGP
BrandyTrust Global Partners Hockessin, Delaware $35.4M AUM
EOCM
Energy Opportunities Capital Management Austin, Texas $34.4M AUM 54.2% 1-Year Est. Return
SJIA
St. James Investment Advisors Port Jefferson, New York $54.6M AUM 0.39% 1-Year Est. Return
LN
Lewin Nick $31.5M AUM

North Run Capital's Q1 2014 Portfolio in Review

As of Q1 2014, North Run Capital held 34 positions worth $984M, up 25% from $789M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

North Run Capital deployed $125M of net new capital in Q1 2014, opening 10 new positions and adding to 4 existing holdings. Its largest new stake was TIBCO SOFTWARE INC: 2,509,850 shares worth $51M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $54.3M trimmed.

  • North Run Capital's largest Q1 2014 buy was TIBCO SOFTWARE INC: 2,509,850 shares worth $51M.
  • North Run Capital added most to General Motors in Q1 2014, an estimated $25.3M increase.
  • North Run Capital's biggest Q1 2014 reduction was Teva Pharmaceuticals, cutting an estimated $54.3M.
  • North Run Capital fully exited Acacia Research in Q1 2014, selling an estimated $22.2M.
  • North Run Capital's ten largest holdings make up 60% of its $984M portfolio in Q1 2014.
  • North Run Capital opened 10 new positions and closed 4 in Q1 2014.
  • North Run Capital's portfolio value rose 25% quarter-over-quarter to $984M.

Based on North Run Capital's 13F filing for Q1 2014, filed 15 May 2014.